California State Teachers Retirement System lessened its position in Chemed Corp. (NYSE:CHE) by 12.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 27,879 shares of the company’s stock after selling 4,146 shares during the period. California State Teachers Retirement System owned about 0.17% of Chemed Corp. worth $5,702,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of CHE. OppenheimerFunds Inc. lifted its stake in shares of Chemed Corp. by 5.4% in the first quarter. OppenheimerFunds Inc. now owns 6,564 shares of the company’s stock worth $1,199,000 after buying an additional 334 shares in the last quarter. Teachers Advisors LLC lifted its stake in shares of Chemed Corp. by 3.0% in the first quarter. Teachers Advisors LLC now owns 30,431 shares of the company’s stock worth $5,559,000 after buying an additional 894 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Chemed Corp. by 30.5% in the first quarter. PNC Financial Services Group Inc. now owns 3,650 shares of the company’s stock worth $668,000 after buying an additional 854 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Chemed Corp. by 7.5% in the first quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock worth $328,070,000 after buying an additional 125,018 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Chemed Corp. by 5.2% in the first quarter. Geode Capital Management LLC now owns 173,435 shares of the company’s stock worth $31,684,000 after buying an additional 8,630 shares in the last quarter. Hedge funds and other institutional investors own 97.24% of the company’s stock.
Chemed Corp. (NYSE CHE) opened at 232.20 on Monday. The company has a market cap of $3.71 billion, a P/E ratio of 57.60 and a beta of 1.13. The company’s 50-day moving average is $200.95 and its 200-day moving average is $199.75. Chemed Corp. has a 12 month low of $132.92 and a 12 month high of $233.50.
Chemed Corp. (NYSE:CHE) last released its earnings results on Thursday, October 26th. The company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $2.00 by $0.15. The company had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. Chemed Corp.’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the business earned $1.73 EPS. On average, equities research analysts expect that Chemed Corp. will post $8.21 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/10/30/california-state-teachers-retirement-system-has-5-70-million-stake-in-chemed-corp-che.html.
In related news, insider Spencer S. Lee sold 1,000 shares of Chemed Corp. stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $197.46, for a total value of $197,460.00. Following the completion of the sale, the insider now directly owns 37,809 shares in the company, valued at approximately $7,465,765.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick P. Grace sold 500 shares of Chemed Corp. stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $201.48, for a total transaction of $100,740.00. Following the completion of the sale, the director now owns 4,515 shares of the company’s stock, valued at $909,682.20. The disclosure for this sale can be found here. 4.90% of the stock is owned by company insiders.
Several research analysts have recently issued reports on CHE shares. Zacks Investment Research downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Royal Bank Of Canada reiterated a “hold” rating and issued a $209.00 target price on shares of Chemed Corp. in a research note on Tuesday, October 3rd. BidaskClub downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. KeyCorp reiterated a “hold” rating on shares of Chemed Corp. in a research note on Friday. Finally, Oppenheimer Holdings, Inc. upped their target price on shares of Chemed Corp. from $220.00 to $225.00 and gave the stock an “outperform” rating in a research note on Friday. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $216.67.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
What are top analysts saying about Chemed Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Chemed Corp. and related companies.